Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig

Virology Journal

Volumn 8, Issue , 2011, Pages

  Jeoung, Hye Young ^a,b   Lee, Won Ha ^b   Jeong, Wooseog ^a   Shin, Bo Hye ^a   Choi, Hwan Won ^c   Lee, Hee Soo ^a   An, Dong Jun ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Kyungpook National University   (South Korea)

^c ChoongAng Vaccine Laboratories Ltd   (South Korea)

Author keywords

EMCV; vaccine candidate; virus like particles

Indexed keywords

ENCEPHALOMYOCARDITIS VIRUS LIKE PARTICLE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; CARDIOVIRUS INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; ENCEPHALOMYOCARDITIS; ENCEPHALOMYOCARDITIS VIRUS; EXPERIMENTAL PIG; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; INJECTION SITE REACTION; NONHUMAN; SWINE; TRANSMISSION ELECTRON MICROSCOPY; VIRUS LIKE AGENT; VIRUS RECOMBINANT; ANIMAL; ANIMAL DISEASE; ARMYWORM; BAGG ALBINO MOUSE; CELL LINE; DRUG TOXICITY; GENETICS; IMMUNOLOGY; MOUSE; PHYSIOLOGY; SWINE DISEASE; ULTRASTRUCTURE; VIRION; VIROLOGY;

ENCEPHALOMYOCARDITIS VIRUS; MUS; PORCINE ENCEPHALOMYOCARDITIS VIRUS; SUIDAE;

ANIMALS; ANTIBODIES, VIRAL; CARDIOVIRUS INFECTIONS; CELL LINE; DRUG TOXICITY; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; SPODOPTERA; SWINE; SWINE DISEASES; VIRAL PROTEINS; VIRION;

EID: 79955121411     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-170     Document Type: Article

References (31)

1. The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region. AC Palmenberg EM Kirby MR Janda NL Drake GM Duke KF Potratz MS Collett, Nucleic Acids Res 1984 12 2969 2985 10.1093/nar/12.6.2969 6324136
2. Reproductive failure in sows following experimental infection with a Belgian EMCV isolate. F Koenen K De Clercq J Lefebvre R Strobbe, Vet Microbiol 1994 39 111 116 10.1016/0378-1135(94)90091-4 8203116 (Pubitemid 24107602)
3. Persistence of encephalomyocarditis virus (EMCV) infection in piglets. C Billinis E Paschaleri-Papadopoulou V Psychas J Vlemmas S Leontides M Koumbati SC Kyriakis O Papadopoulos, Vet Microbiol 1999 70 171 177 10.1016/S0378-1135(99) 00137-6 10596801
4. Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditis. D Gelmetti A Meroni E Brocchi F Koenen G Cammarata, Vet Res 2006 37 15 23 10.1051/vetres:2005041 16336922 (Pubitemid 43067011)
5. The efficacy of an experimental oil-adjuvanted encephalomyocarditis vaccine in elephants, mice and pigs. P Hunter SP Swanepoel JJ Esterhuysen JP Raath RG Bengis JJ van der Lugt, Vaccine 1998 16 55 61 10.1016/S0264-410X(97) 00158-8 9607009 (Pubitemid 27504804)
6. Antibody response in baboons (Papio cynocephalus anubis) to a commercially available encephalomyocarditis virus vaccine. RB Huneke MG Michaels CL Kaufman ST Ildstad, Lab Anim Sci 1998 48 526 528 10090069
7. Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus. HY Jeoung WH Lee W Jeong YJ Ko CU Choi DJ An, Res Vet Sci 89 295 300 10.1016/j.rvsc.2010.03.012 20378136
8. Virus-like particles as immunogens. R Noad P Roy, Trends Microbiol 2003 11 438 444 10.1016/S0966-842X(03)00208-7 13678860 (Pubitemid 37101484)
9. Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. R Schirmbeck W Bohm J Reimann, Intervirology 1996 39 111 119 8957677
10. Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses. P Rueda JL Martinez-Torrecuadrada J Sarraseca C Sedlik M del Barrio A Hurtado C Leclerc JI Casal, Vaccine 1999 18 325 332 10.1016/S0264-410X(99)00202-9 10506659 (Pubitemid 29444008)
11. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. JM Ball DY Graham AR Opekun MA Gilger RA Guerrero MK Estes, Gastroenterology 1999 117 40 48 10.1016/S0016-5085(99)70548-2 10381908 (Pubitemid 29297618)
12. Use of baculovirus expression vectors: development of diagnostic reagents, vaccines and morphological counterparts of bluetongue virus. P Roy, FEMS Microbiol Immunol 1990 2 223 234 10.1111/j.1574-6968.1990.tb03523.x 2178355 (Pubitemid 20354561)
13. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. S Laurent JF Vautherot MF Madelaine G Le Gall D Rasschaert, J Virol 1994 68 6794 6798 8084017 (Pubitemid 24294936)
14. Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. E Mortola P Roy, FEBS Lett 2004 576 174 178 10.1016/j.febslet.2004.09.009 15474033 (Pubitemid 39330479)
15. Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses". G Belliot JS Noel JF Li Y Seto CD Humphrey T Ando RI Glass SS Monroe, J Clin Microbiol 2001 39 4288 4295 10.1128/JCM.39.12.4288-4295.2001 11724834 (Pubitemid 33117112)
16. A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure. AF Antonis CJ Bruschke P Rueda L Maranga JI Casal C Vela LA Hilgers PB Belt K Weerdmeester MJ Carrondo JP Langeveld, Vaccine 2006 24 5481 5490 10.1016/j.vaccine.2006.03.089 16730104 (Pubitemid 43831379)
17. Encephalomyocarditis in Korea: serological survey in pigs and phylogenetic analysis of two historical isolates. DJ An W Jeong HY Jeoung SH Yoon HJ Kim CU Choi BK Park, Vet Microbiol 2009 137 37 44 10.1016/j.vetmic.2009. 01.005 19200668
18. DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. B Bellier C Huret M Miyalou D Desjardins MP Frenkiel P Despres F Tangy C Dalba D Klatzmann, Vaccine 2009 27 5772 5780 10.1016/j.vaccine.2009.07.059 19656495
19. High level expression of nonfused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors. VA Luckow MD Summers, Virology 1989 170 31 39 10.1016/0042-6822(89)90348-6 2497580 (Pubitemid 19133961)
20. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. YC Hu JT Hsu JH Huang MS Ho YC Ho, Biotechnol Lett 2003 25 919 925 10.1023/A:1024071514438 12889824 (Pubitemid 36796909)
21. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. DC Ansardi DC Porter CD Morrow, J Virol 1991 65 2088 2092 1848318
22. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs. Y Cao Z Lu J Sun X Bai P Sun H Bao Y Chen J Guo D Li X Liu Z Liu, Vet Microbiol 2009 137 10 17 10.1016/j.vetmic.2008.12.007 19167843
23. Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus. Z Chen X Guo X Ge H Jia H Yang, Vaccine 2008 26 573 580 10.1016/j.vaccine.2007.11.027 18162265
24. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay. YJ Ko KS Choi JJ Nah DJ Paton JK Oem G Wilsden SY Kang NI Jo JH Lee JH Kim, et al. Clin Diagn Lab Immunol 2005 12 922 929 16085909
25. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. YC Chung MS Ho JC Wu WJ Chen JH Huang ST Chou YC Hu, Vaccine 2008 26 1855 1862 18329759
26. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles. H Jin W Xiao C Xiao Y Yu Y Kang X Du X Wei B Wang, Viral Immunol 2007 20 429 440 10.1089/vim.2007.0031 17931113 (Pubitemid 47585320)
27. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. P Pushko TM Tumpey F Bu J Knell R Robinson G Smith, Vaccine 2005 23 5751 5759 10.1016/j.vaccine.2005.07.098 16143432 (Pubitemid 41668881)
28. Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. X Paliard Y Liu R Wagner H Wolf J Baenziger CM Walker, AIDS Res Hum Retroviruses 2000 16 273 282 10.1089/088922200309368 10710215 (Pubitemid 30111963)
29. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. C Fromantin B Jamot J Cohen L Piroth P Pothier E Kohli, J Virol 2001 75 11010 11016 10.1128/JVI.75.22.11010-11016.2001 11602741 (Pubitemid 33031568)
30. Serologic responses of Barbary sheep (Ammotragus lervia), Indian antelope (Antilope cervicapra), wallaroos (Macropus robustus), and chimpanzees (Pan troglodytes) to an inactivated encephalomyocarditis virus vaccine. DJ McLelland PD Kirkland KA Rose RJ Dixon N Smith, J Zoo Wildl Med 2005 36 69 73 10.1638/03-054 17315459 (Pubitemid 40793355)
31. Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus. JE Osorio GB Hubbard KF Soike M Girard S van der Werf JC Moulin AC Palmenberg, Vaccine 1996 14 155 161 10.1016/0264-410X(95)00129-O 8852413 (Pubitemid 26072862)